ProMIS Neurosciences (NASDAQ:PMN) Earns “Buy” Rating from Guggenheim
Guggenheim reissued their buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report released on Tuesday morning,Benzinga reports. Guggenheim currently has a $6.00 target price on the stock. ProMIS Neurosciences Stock Performance Shares of NASDAQ:PMN opened at $0.73 on Tuesday. The firm has a market capitalization of $23.93 million, a PE […]
Guggenheim reissued their buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report released on Tuesday morning,Benzinga reports. Guggenheim currently has a $6.00 target price on the stock. ProMIS Neurosciences Stock Performance Shares of NASDAQ:PMN opened at $0.73 on Tuesday. The firm has a market capitalization of $23.93 million, a PE […]
